CareDx Financial Statements (CDNA)
|
|
|
|
Report date
|
|
|
28.02.2020 |
24.02.2021 |
24.02.2022 |
27.02.2023 |
31.12.2023 |
|
04.11.2024 |
|
Currency
|
|
|
USD |
USD |
USD |
USD |
USD |
|
USD |
|
Financial report URL
|
|
|
|
|
|
|
|
|
|
|
|
Revenue, bln rub |
? |
|
127.1 |
192.2 |
296.4 |
321.8 |
280.3 |
|
312.8 |
|
Operating Income, bln rub |
|
|
-24.5 |
-17.7 |
-29.7 |
-77.2 |
-101.9 |
|
-57.7 |
|
EBITDA, bln rub |
? |
|
-19.0 |
-10.2 |
-17.8 |
-61.2 |
-89.7 |
|
-36.7 |
|
Net profit, bln rub |
? |
|
-22.0 |
-18.7 |
-30.7 |
-76.6 |
-190.3 |
|
-143.6 |
|
|
OCF, bln rub |
? |
|
-2.77 |
33.4 |
-19.3 |
-25.2 |
-18.4 |
|
7.78 |
|
CAPEX, bln rub |
? |
|
3.35 |
10.4 |
20.3 |
24.3 |
9.24 |
|
8.15 |
|
FCF, bln rub |
? |
|
-6.12 |
23.1 |
-39.6 |
-49.6 |
-27.6 |
|
6.18 |
|
Dividend payout, bln rub
|
|
|
0.000 |
0.000 |
0.000 |
0.000 |
0.000 |
|
0.000 |
|
|
Ordinary share dividend yield, %
|
|
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
|
0.00% |
|
Dividend payout ratio, %
|
|
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
|
0 |
|
|
OPEX, bln rub |
|
|
106.1 |
146.8 |
228.7 |
286.8 |
277.8 |
|
289.1 |
|
Cost of production, bln rub |
|
|
45.5 |
63.1 |
97.4 |
112.2 |
102.0 |
|
109.0 |
|
R&D, bln rub |
|
|
30.7 |
48.9 |
76.5 |
90.4 |
81.9 |
|
74.2 |
|
Interest expenses, bln rub |
|
|
0.000 |
0.271 |
0.000 |
3.76 |
0.000 |
|
0.000 |
|
|
Assets, bln rub |
|
|
151.7 |
368.5 |
566.6 |
543.0 |
466.8 |
|
477.0 |
|
Net Assets, bln rub |
? |
|
99.0 |
277.7 |
465.9 |
430.9 |
261.3 |
|
273.2 |
|
Debt, bln rub |
|
|
3.02 |
16.1 |
17.4 |
39.0 |
34.2 |
|
23.8 |
|
Cash, bln rub |
|
|
38.2 |
224.7 |
348.5 |
293.1 |
235.4 |
|
240.9 |
|
Net debt, bln rub |
|
|
-35.2 |
-208.6 |
-331.1 |
-254.1 |
-201.2 |
|
-217.0 |
|
|
Ordinary share price, rub |
|
|
21.6 |
72.5 |
45.5 |
11.4 |
12.0 |
|
5.96 |
|
Number of ordinary shares, mln |
|
|
42.2 |
46.5 |
52.2 |
53.3 |
53.8 |
|
52.9 |
|
|
Market cap, bln rub |
|
|
909 |
3 368 |
2 376 |
608 |
645 |
|
315 |
|
EV, bln rub |
? |
|
874 |
3 159 |
2 045 |
354 |
444 |
|
98 |
|
Book value, bln rub |
|
|
30 |
209 |
379 |
350 |
175 |
|
193 |
|
|
EPS, rub |
? |
|
-0.52 |
-0.40 |
-0.59 |
-1.44 |
-3.54 |
|
-2.71 |
|
FCF/share, rub |
|
|
-0.15 |
0.50 |
-0.76 |
-0.93 |
-0.51 |
|
0.12 |
|
BV/share, rub |
|
|
0.70 |
4.51 |
7.25 |
6.57 |
3.26 |
|
3.64 |
|
|
EBITDA margin, % |
? |
|
-15.0% |
-5.31% |
-6.02% |
-19.0% |
-32.0% |
|
-11.7% |
|
Net margin, % |
? |
|
-17.3% |
-9.74% |
-10.3% |
-23.8% |
-67.9% |
|
-45.9% |
|
FCF yield, % |
? |
|
-0.67% |
0.69% |
-1.66% |
-8.15% |
-4.28% |
|
1.96% |
|
ROE, % |
? |
|
-22.2% |
-6.74% |
-6.58% |
-17.8% |
-72.8% |
|
-52.5% |
|
ROA, % |
? |
|
-14.5% |
-5.08% |
-5.41% |
-14.1% |
-40.8% |
|
-30.1% |
|
|
P/E |
? |
|
-41.4 |
-180.0 |
-77.5 |
-7.94 |
-3.39 |
|
-2.20 |
|
P/FCF |
|
|
-148.6 |
146.0 |
-60.1 |
-12.3 |
-23.4 |
|
51.0 |
|
P/S |
? |
|
7.16 |
17.5 |
8.02 |
1.89 |
2.30 |
|
1.01 |
|
P/BV |
? |
|
30.7 |
16.1 |
6.27 |
1.74 |
3.68 |
|
1.64 |
|
EV/EBITDA |
? |
|
-46.0 |
-309.5 |
-114.6 |
-5.79 |
-4.95 |
|
-2.68 |
|
Debt/EBITDA |
|
|
1.85 |
20.4 |
18.6 |
4.15 |
2.24 |
|
5.91 |
|
|
R&D/CAPEX, % |
|
|
917.0% |
472.4% |
377.7% |
371.4% |
886.0% |
|
910.1% |
|
|
CAPEX/Revenue, % |
|
|
2.64% |
5.39% |
6.84% |
7.56% |
3.30% |
|
2.61% |
|
| CareDx shareholders |
